1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC077G |
Quality Control | All cells test negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Fibroblast |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Orbital Tissue |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Orbital Cells |
Passage Number | 1 |
Human orbital fibroblasts, isolated from the connective tissue of the orbit, are distinct from fibroblasts derived from dermal and other extraorbital sources. In culture, they exhibit unique responses to stimuli, such as binding endothelin and producing high levels of IL-6 upon IL-1β treatment, linking them to inflammation and immune responses. These fibroblasts play a crucial role in Graves’ ophthalmopathy (GO), where excessive activity contributes to disease pathogenesis. Activated by immune cell interactions and soluble factors, orbital fibroblasts express the thyrotropin receptor (TSHR), with autoantibodies targeting TSHR potentially linking Graves’ disease and GO through proinflammatory cytokine production.
Why choose Human Orbital Fibroblasts from AcceGen?
AcceGen ensures Human Orbital Fibroblasts are from expert isolation and cryopreserved at an early passage, which helps maintain cell integrity and functionality. The cells exhibit high viability, making them ideal for research purposes. AcceGen also provides fast and reliable transport to preserve cell quality, ensuring they arrive in optimal condition.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
FOR RESEARCH USE ONLY
Human orbital fibroblasts serve as a vital model for investigating diseases related to the connective tissue of the orbit, such as Graves’ ophthalmopathy (GO), also known as thyroid-associated ophthalmopathy (TAO). These fibroblasts help researchers study the significant inflammation characteristic of these conditions, where tissues are infiltrated by activated T lymphocytes and mast cells, leading to excessive accumulation of hyaluronan. Using human orbital fibroblasts in research enables the exploration of communication pathways between fibroblasts and immune cells, providing insights into the mechanisms driving inflammation and disease progression, which could inform potential therapeutic approaches.
Human orbital fibroblasts are specialized cells found in the connective tissue of the orbit. They help maintain the structural integrity of the orbit, produce extracellular matrix components, and contribute to tissue repair and remodeling. They are also involved in various physiological and pathological processes, including inflammation and fibrosis.
Human orbital fibroblasts are usually obtained from biopsy samples of orbital tissue. For culturing, these cells are grown in specialized media that support their growth and maintain their functionality. The media often contain nutrients, growth factors, and supplements to mimic the natural environment of orbital fibroblasts.
Human orbital fibroblasts are used to study conditions like thyroid eye disease (Graves’ orbitopathy), orbital inflammation, and fibrosis. They are important for developing and testing new treatments for these conditions and for understanding the mechanisms of tissue remodeling and scarring in the orbital region.
Key characteristics include their spindle-shaped morphology, proliferation rate, and expression of specific markers like vimentin and fibronectin. They should show healthy growth patterns, proper cell-to-cell interactions, and responsiveness to changes in media composition or the introduction of pharmacological agents.
Challenges include maintaining their viability and functionality in vitro, replicating the complex natural environment, and preventing contamination. Variability between primary fibroblast cultures from different donors can affect experimental consistency. Another challenge is the potential for fibroblasts to become myofibroblasts under certain conditions, which can change their behavior and affect experimental results.